Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
A man became so frustrated with noise from a nearby building site that he shot a builder with an air rifle, police say.
A backbench revolt over proposals to ease purdah restrictions on the EU referendum has led to a government climb down.
It's been a colder start to the day, especially in rural areas of Britain.